Corporation
GE HealthCare Technologies Canada
- Meetings this Parliament
- 22
- With MPs
- 6
- Since Nov 2021
- 65
- Active registrations
- 1
Most recent reported meeting: Aug 6, 2026.
Lobbying by GE HealthCare Technologies Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
In-house (corporation) In effect since Apr 29, 2026
Filed by Michael Hamilton, President and Chief Executive Officer
Lobbyists
- Brigid Buckingham · Director, Government Affairs & Policy
- Michael Hamilton · President and Chief Executive Officer
Institutions they may lobby: CUSMA Secretariat, Competition Bureau Canada (COBU), Environment and Climate Change Canada (ECCC), Export Development Canada (EDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Research Council (NRC), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Services and Procurement Canada (PSPC), Senate of Canada, Treasury Board Of Canada Secretariat (TBS)
What they're lobbying on (8)Hide details
- strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
- export permits and export controls
- • Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
- Substances addressed in the third phase of the Chemicals Management Plan.
- Support from ISED, with respect to Strategic Innovation Fund
- Medical device cost recovery schemes with respect to filing fees
- Engage in pre-market and post-market regulatory requirements to ensure efficient and predictable processes that supports safety, effectiveness, quality, and Canada’s competitiveness in the medical device sector.
- Amendments to Copyright Act, regarding Technology Protection Measures (TPMs)
Registration 777017-4978-74. Look it up in the official Registry
Reported meetings
SpreadsheetFiled by Michael Hamilton (36), Heather Chalmers (29).
-
Reported by Michael Hamilton · In-house (corporation)
- Janice Charette · Chief Trade Negotiator to the United States, Privy Council Office (PCO)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
-
Reported by Michael Hamilton · In-house (corporation)
- Madeleine Féquière · Consul General of Canada in Chicago, Global Affairs Canada (GAC)
- Julien Rosen · Trade Commissioner, Life Sciences, Global Affairs Canada (GAC)
- Cory Olishansky · Consul and Trade Commissioner, Global Affairs Canada (GAC)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
-
Reported by Michael Hamilton · In-house (corporation)
- Carlos Vanderloo · Counsellor - Economic and Trade Policy, Global Affairs Canada (GAC)
- Kaitlyn Pritchard · Trade Program Manager, Innovation & Industrial Policy, Global Affairs Canada (GAC)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
-
Reported by Michael Hamilton · In-house (corporation)
- Martin Moen · Associate Asst Dep. Minister of International Trade and Chair of the Canada/U.S. Trade and Economic Task Force, Global Affairs Canada (GAC)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
-
Reported by Michael Hamilton · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review. Read more
• Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
-
Reported by Michael Hamilton · In-house (corporation)
- Ajay Nandalall · Senior Special Assistant, Global Affairs Canada (GAC)
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Ajay Nandalall · Senior Special Assistant, Global Affairs Canada (GAC)
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Taras Zalusky · Chief of Staff, Global Affairs Canada (GAC)
- Ajay Nandalall · Senior Special Assistant, Global Affairs Canada (GAC)
- Borna Najafi · Special Assistant - Executive Assistant, Global Affairs Canada (GAC)
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Manuela Tomic · Sr Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- David McFarlane · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
strategic policy objectives for the MedTech sector regarding 2026 CUSMA review.
-
Reported by Michael Hamilton · In-house (corporation)
- Yasir Naqvi · Parliamentary Secretary to the Minister of International Trade and Parliamentary Secretary to the Secretary of State (International Development), Global Affairs Canada (GAC)
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Yasir Naqvi · Parliamentary Secretary, Global Affairs Canada (GAC)
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Anita Anand · Minister, Global Affairs Canada (GAC)
- Marjorie Michel · Minister, Health Canada (HC)
- David Morrison · Deputy Minister, Global Affairs Canada (GAC)
- Nathalie G. Drouin · Deputy Clerk of the Privy Council and National Security and Intelligence Advisor to the Prime Minister, Privy Council Office (PCO)
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Charles Sousa · Member of Parliament
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Yasir Naqvi · Parliamentary Secretary, Global Affairs Canada (GAC)
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Taras Zelusky · Chief of Staff, Global Affairs Canada (GAC)
- Ajay Nandalall · Senior Advisor, Global Affairs Canada (GAC)
- Lisa Jorgensen · Senior Advisor, Prime Minister's Office (PMO)
- Scott gilmore · Senior Advisor, Prime Minister's Office (PMO)
export permits and export controls
-
Reported by Michael Hamilton · In-house (corporation)
- Yasir Naqvi · Parliamentary Secretary, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
-
Reported by Michael Hamilton · In-house (corporation)
- David Morrison · Deputy Minister, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
-
Reported by Michael Hamilton · In-house (corporation)
- Lisa Jorgensen · Policy Director, Global Affairs, Prime Minister's Office (PMO)
- Scott Gilmore · Senior Advisor on Foreign, Defence, and Security Policy, Prime Minister's Office (PMO)
• Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
-
Reported by Michael Hamilton · In-house (corporation)
- Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
- Jade Mallette · Chief of Staff, Health Canada (HC)
• Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
-
Reported by Michael Hamilton · In-house (corporation)
- Leslie Scanlon · Ambassador Extraordinary and Plenipotentiary to the State of Israel, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
-
Reported by Michael Hamilton · In-house (corporation)
- Ajay Nandallal · Senior Advisor, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
-
Reported by Michael Hamilton · In-house (corporation)
- Taras Zelusky · Chief of Staff, Global Affairs Canada (GAC)
• Government investments in Artificial Intelligence (AI) compute infrastructure; • Government policy considerations on health data trust and privacy.
-
Reported by Michael Hamilton · In-house (corporation)
- Danielle Boyle · Director of Operations, Finance Canada (FIN)
Support from ISED, with respect to Strategic Innovation Fund
-
Reported by Michael Hamilton · In-house (corporation)
- Greg Orencsak · Deputy Minister, Health Canada (HC)
- Jocelyne Voisin · Senior Assistant Deputy Ministry, Health Canada (HC)
Engage in pre-market and post-market regulatory requirements to ensure efficient and predictable processes that supports safety, effectiveness, quality, and Canada’s competitiveness in the medical device sector. Read more
-
Reported by Michael Hamilton · In-house (corporation)
- Greg Orencsak · Deputy Minister, Health Canada (HC)
- Jocelyne Voisin · Senior Assistant Deputy Ministry, Health Canada (HC)
Engage in pre-market and post-market regulatory requirements to ensure efficient and predictable processes that supports safety, effectiveness, quality, and Canada’s competitiveness in the medical device sector. Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.